---
schema_version: "secwatch.filing_event.v1"
accession: "0001867096-22-000111"
form_type: "8-K"
ticker: "XERS"
cik: "0001867096"
company_name: "Xeris Biopharma Holdings, Inc."
filed_at: "2022-10-03T23:59:59+00:00"
generated_at: "2026-06-23T06:07:35.422503+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Xeris Biopharma enters amended lease for 87,032 sq ft Chicago HQ; base rent $52.50/sq ft

## Summary
- Xeris Pharma leases 87,032 sq ft office/lab at 1375 W. Fulton, Chicago; term through 2037.
- Annual base rent $52.50/sq ft in year one, escalating 2.5% annually; rent abatement for first 12 months.
- Letter of credit increased from $408,263 to $3,247,808 to secure lease obligations.
- Company to relocate HQ to premises in H1 2023; current HQ at 180 N. LaSalle to be subleased.
- Credit agreement amended to permit issuance of the letter of credit.

## SEC filing metadata
- accession: 0001867096-22-000111
- form_type: 8-K
- ticker: XERS
- cik: 0001867096
- company_name: Xeris Biopharma Holdings, Inc.
- filed_at: 2022-10-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867096/000186709622000111/0001867096-22-000111-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867096/000186709622000111/xers-20220929.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001867096-22-000111
- JSON: https://secwatch.observer/filing/0001867096-22-000111.json
- Plain text: https://secwatch.observer/filing/0001867096-22-000111.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.